Hepatitis C Virus Vaccines
New hepatitis C virus vaccines research from E. Fenouillet et al outlined
Published in Vaccine Weekly, October 29th, 2008
Fresh data on hepatitis C virus are presented in the report 'Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity.' According to a study from France, "Disulfide bonding contributes to the function and antigenicity of many viral envelope glycoproteins. We assessed here its significance for the hepatitis C virus E2 envelope protein and a counterpart deleted for hypervariable region-1 (HVR1)."
"All 18 cysteine residues of the antigens were involved in disulfides. Chemical reduction of up to half of these disulfides was compatible with anti-E2 monoclonal antibody reaction, CD81 receptor binding, and viral entry, whereas complete...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-10-29)
More Articles from Vaccine Weekly
- Imperial College London
Polio could be wiped out in Nigeria thanks to improved vaccine, says study - Acne Vulgaris
New acne vulgaris research from University of California described - DNA Research
New DNA research study findings have been published by scientists at Zhejiang University - Immunization
New findings from Montana State University in the area of immunization published - Immunotherapy
New findings from H. Henmar and co-authors in the area of immunotherapy published - Leishmaniasis
New research on leishmaniasis from R.B.G. Azeredocoutinho and co-authors summarized - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
